{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:41:42Z","timestamp":1790710902218,"version":"4.1.0"},"reference-count":122,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>This review focuses on the clinical translation of preclinical studies, especially those that have used stem cells in the treatment of glaucoma, with an emphasis on optic nerve regeneration. The studies referred to in the review aim to treat optic nerve atrophy, while cell therapies targeting other sites in the eye, such as the trabecular meshwork, have not been addressed. Such complex and varied pathophysiological mechanisms that lead to glaucoma may explain the fact that although stem cells have a high capacity of neuronal regeneration, the treatments performed did not have the expected results and the promise offered by animal studies was not achieved. By analyzing the facts associated with failure, important lessons are to be learned: the type of stem cells that are used, the route of administration, the selection of patients eligible for these treatments, additional therapies that support stem cells transplantation and their mode of action, methods of avoiding the host\u2019s immune response. Many of these problems could be solved using exosomes (EV), but also miRNA, which allows more targeted approaches with minimal side effects.<\/jats:p>","DOI":"10.3390\/ijms222011077","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T09:10:49Z","timestamp":1634202649000},"page":"11077","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-2044","authenticated-orcid":false,"given":"Simona Delia","family":"Nicoar\u0103","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 8 Victor Babe\u0219 Street, 400012 Cluj-Napoca, Romania"},{"name":"Clinic of Ophthalmology, Emergency County Hospital, 3\u20135 Clinicilor Street, 40006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Brie","sequence":"additional","affiliation":[{"name":"\u201cIon Chiricu\u021b\u0103\u201d Institute of Oncology, Laboratory of Cell Biology and Radiobiology, 34\u201336 Republicii Street, 400010 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancu\u021ba","family":"Jurj","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 8 Victor Babe\u0219 Street, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9270-8529","authenticated-orcid":false,"given":"Olga","family":"Sori\u021b\u0103u","sequence":"additional","affiliation":[{"name":"\u201cIon Chiricu\u021b\u0103\u201d Institute of Oncology, Laboratory of Cell Biology and Radiobiology, 34\u201336 Republicii Street, 400010 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s40135-015-0081-9","article-title":"Human pluripotent stem cell-derived retinal ganglion cells: Applications for the study and treatment of optic neuropathies","volume":"3","author":"Cooke","year":"2015","journal-title":"Curr. Ophthalmol. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.drudis.2010.02.007","article-title":"Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies","volume":"15","author":"Vijay","year":"2010","journal-title":"Drug Discov. Today"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00441-013-1646-2","article-title":"The potential of stem cell research for the treatment of neuronal damage in glaucoma","volume":"353","author":"Karl","year":"2013","journal-title":"Cell Tissue Res."},{"key":"ref_4","first-page":"2081","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040","volume":"121","author":"Tham","year":"2014","journal-title":"A Syst. Rev. Meta-Anal."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): A systematic review and meta-analysis","volume":"100","author":"Kapetanakis","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00441-013-1596-8","article-title":"Glaucoma and optic nerve repair","volume":"353","author":"Diekmann","year":"2013","journal-title":"Cell Tissue Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(92)31774-9","article-title":"Prevalence of glaucoma. The beaver dam eye study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4103\/1673-5374.259600","article-title":"Normal tension glaucoma: From the brain to the eye or the inverse?","volume":"14","author":"Zhang","year":"2019","journal-title":"Neural Regen. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10792-017-0795-9","article-title":"Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: A review of the literature","volume":"39","author":"Evangelho","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"ref_10","first-page":"1745","article-title":"Transforming growth factor-\u03b22 increases extracellular matrix proteins in optic nerve head cells via activation","volume":"17","author":"Zode","year":"2011","journal-title":"Mol. Vis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Parsadaniantz, S.M., R\u00e9aux-le Goazigo, A., Sapienza, A., Habas, C., and Baudouin, C. (2020). Glaucoma: A degenerative optic neuropathy related to neuroinflammation?. Cells, 9.","DOI":"10.3390\/cells9030535"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICU.0b013e3280895aea","article-title":"Glaucoma as a neurodegenerative disease","volume":"18","author":"Gupta","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_13","first-page":"50","article-title":"Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer\u2019s disease","volume":"18","author":"Parisi","year":"2003","journal-title":"Semin. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archopht.1995.01100070092031","article-title":"Risk factors for open-angle glaucoma. The barbados eye study","volume":"113","author":"Leske","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e000032","DOI":"10.1136\/bmjophth-2016-000032","article-title":"Retinal vasculature in glaucoma: A review","volume":"1","author":"Chan","year":"2017","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_16","first-page":"1599","article-title":"Parapapillary retinal vessel diameter in normal and glaucoma eyes. I. Morphometric data","volume":"30","author":"Jonas","year":"1989","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1755-3768.2009.01573.x","article-title":"Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma","volume":"88","author":"Fadini","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e3055","DOI":"10.1097\/MD.0000000000003055","article-title":"Association between peripheral vascular endothelial function and progression of open-angle glaucoma","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ICU.0b013e3282f3919b","article-title":"Normal-tension glaucoma: Is it different from primary open-angle glaucoma?","volume":"19","author":"Shields","year":"2008","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"529082","DOI":"10.1155\/2014\/529082","article-title":"Systemic endothelial function in primary open-angle glaucoma","volume":"2014","author":"Atas","year":"2014","journal-title":"J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00947082","article-title":"Endothelin-like immunoreactivity in aqueous humor of patients with primary open -angle glaucoma and cataract","volume":"235","author":"Noske","year":"1997","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00061198-199704000-00003","article-title":"Plasma and aqueous humor endothelin levels in primary open-angle glaucoma","volume":"6","author":"Tezel","year":"1997","journal-title":"J. Glaucoma"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1167\/iovs.02-0913","article-title":"Effects of cold-induced vasospasm in glaucoma: The role of endothelin-1","volume":"44","author":"Nicolela","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_25","first-page":"2704","article-title":"Human optic nerve head astrocytes as a target for endothelin-1","volume":"43","author":"Prasanna","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1167\/iovs.06-1138","article-title":"Endothelin-1-mediating signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes","volume":"48","author":"He","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/1673-5374.245465","article-title":"Neuroinflammation as a target for glaucoma therapy","volume":"14","author":"Adornetto","year":"2019","journal-title":"Neural Regen. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3389\/fneur.2020.612422","article-title":"The role of neuroinflammation in glaucoma: An update on molecular mechanisms and new therapeutic options","volume":"11","author":"Rolle","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fimmu.2018.01017","article-title":"Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma","volume":"9","author":"Toth","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41467-018-05681-9","article-title":"Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","article-title":"The role of microglia in retinal neurodegeneration: Alzheimer\u2019s Disease, Parkinson, and Glaucoma","volume":"9","author":"Ramirez","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"a017269","DOI":"10.1101\/cshperspect.a017269","article-title":"The complex role of neuroinflammation in glaucoma","volume":"4","author":"Soto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","article-title":"Lasker\/IRRF Initiative on Astrocytes and Glaucomatous Neurodegeneration Participants. Neuroinflammation in glaucoma: A new opportunity","volume":"157","author":"Williams","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"610788","DOI":"10.3389\/fnins.2021.610788","article-title":"The interaction between microglia and macroglia in glaucoma","volume":"15","author":"Zhao","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_35","unstructured":"Barret, J.E., Page, C.P., and Michel, M.C. (2017). Translational pharmacology in glaucoma neuroprotection. Handbook of Experimental Pharmacology, Springer International Publishing. [1st ed.]."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ophtha.2009.06.058","article-title":"Cerebrospinal fluid pressure in glaucoma: A prospective study","volume":"117","author":"Ren","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_37","first-page":"431","article-title":"Chronology of optic nerve head and retinal responses to elevated intraocular pressure","volume":"41","author":"Johnson","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.exer.2009.02.004","article-title":"Neurotrophin roles in retinal ganglion cell survival: Lessons from rat glaucoma models","volume":"88","author":"Johnson","year":"2009","journal-title":"Exp. Eye Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00006324-200102000-00008","article-title":"Beyond intraocular pressure: Neuroprotective strategies for future glaucoma therapies","volume":"78","author":"Hartwick","year":"2001","journal-title":"Optom. Vis. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archopht.121.2.183","article-title":"Vitreous amino acids concentrations in patients with glaucoma undergoing vitrectomy","volume":"121","author":"Honkanen","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1471-4159.2005.03214.x","article-title":"Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging","volume":"94","author":"Hartwick","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archopht.123.1.64","article-title":"Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma","volume":"123","author":"Wamsley","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00441-013-1637-3","article-title":"Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper","volume":"353","author":"Tamm","year":"2013","journal-title":"Cell Tissue Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exer.2017.01.007","article-title":"Lasker\/IRRF initiative on astrocytes and glaucomatous neurodegeneration participants. The challenge of regenerative therapies for the optic nerve in glaucoma","volume":"157","author":"Calkins","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02284793","article-title":"Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve","volume":"25","author":"Berry","year":"1996","journal-title":"J. Neurocytol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/WCO.0000000000000777","article-title":"Neuro-protection and neuro-regeneration of the optic nerve: Recent advances and future directions","volume":"33","author":"Gokoffski","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41433-018-0050-2","article-title":"Neuroprotective agents in the management of glaucoma","volume":"32","author":"Nucci","year":"2018","journal-title":"Eye"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0079-6123(08)01125-4","article-title":"Astrocytes in glaucomatous optic neuropathy","volume":"173","author":"Hernandez","year":"2008","journal-title":"Prog. Brain Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/eop.11.3","article-title":"Stem cell therapy for glaucoma: Possibilities and practicalities","volume":"6","author":"Johnson","year":"2011","journal-title":"Expert Rev. Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9415367","DOI":"10.1155\/2018\/9415367","article-title":"Bioprocessing of mesenchymal stem cells and their derivatives: Toward cell-free therapeutics","volume":"2018","author":"Phelps","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.111.249243","article-title":"Immunogenicity of pluripotent stem cells and their derivatives","volume":"112","author":"Ransohoff","year":"2013","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-cellbio-100913-013132","article-title":"\u201cMesenchymal\u201d stem cells","volume":"30","author":"Bianco","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/stem.2812","article-title":"Human periodontal ligament-derived stem cells promote retinal ganglion cell survival and axon regeneration after optic nerve injury","volume":"36","author":"Cen","year":"2018","journal-title":"Stem Cells"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: Progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Kot","year":"2019","journal-title":"Cell Transpl."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4252\/wjsc.v13.i5.366","article-title":"Stem cell therapy in ocular pathologies in the past 20 years","volume":"13","author":"Miotti","year":"2021","journal-title":"World J. Stem Cells"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMoa1609583","article-title":"Vision loss after intravitreal injection of autologous \u201cstem cells\u201d for AMD","volume":"376","author":"Kuriyan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3928\/23258160-20170829-16","article-title":"Bilateral retinal detachments after intravitreal injection of adipose-derived \u2018stem cells\u2019 in a patient with exudative macular degeneration","volume":"48","author":"Saraf","year":"2017","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3928\/23258160-20160601-16","article-title":"Retinal detachment after subretinal stem cell transplantation","volume":"47","author":"Leung","year":"2016","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/2229-3485.134306","article-title":"Glaucoma clinical trial design: A review of the literature","volume":"5","author":"Stewart","year":"2014","journal-title":"Perspect. Clin. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fnins.2018.00651","article-title":"Pluripotent stem cell-based approaches to explore and treat optic neuropathies","volume":"12","author":"Rabesandratana","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajo.2017.04.006","article-title":"Experience with a subretinal cell-based therapy in patients with geographic atrophy secondary to age-related macular degeneration","volume":"179","author":"Ho","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1167\/iovs.12-9970","article-title":"Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases","volume":"53","author":"Kauper","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10633-021-09817-z","article-title":"Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma","volume":"143","author":"Vilela","year":"2021","journal-title":"Doc. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4252\/wjsc.v8.i11.376","article-title":"Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials","volume":"8","author":"Pastor","year":"2016","journal-title":"World J. Stem Cells"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4103\/1673-5374.165525","article-title":"Stem cell ophthalmology treatment study (SCOTS) for retinal and optic nerve diseases: A case report of improvement in relapsing auto-immune optic neuropathy","volume":"10","author":"Weiss","year":"2015","journal-title":"Neural Regen. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.21037\/sci.2017.11.05","article-title":"Stem cell ophthalmology treatment study: Bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION)","volume":"4","author":"Weiss","year":"2017","journal-title":"Stem Cell Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/sci.2019.11.01","article-title":"Stem cell ophthalmology treatment study (SCOTS): Bone marrow derived stem cells in the treatment of dominant optic atrophy","volume":"6","author":"Weiss","year":"2019","journal-title":"Stem Cell Investig."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Weiss, J.N., and Levy, S. (2020). Stem cell ophthalmology treatment study (SCOTS): Bone Marrow-derived stem cells in the treatment of age-related macular degeneration. Medicines, 7.","DOI":"10.3390\/medicines7040016"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4103\/1673-5374.193251","article-title":"Stem cell ophthalmology treatment study (SCOTS): Bone marrow-derived stem cells in the treatment of Leber\u2019s hereditary optic neuropathy","volume":"11","author":"Weiss","year":"2016","journal-title":"Neural Regen. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13287-020-01870-w","article-title":"Management of retinitis pigmentosa by Wharton\u2019s jelly-derived mesenchymal stem cells: Prospective analysis of 1-year results","volume":"11","author":"Arslan","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13287-021-02351-4","article-title":"Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy","volume":"12","author":"Limoli","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s10792-019-01141-5","article-title":"Six-month results of suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with optic atrophy: A phase 1\/2 study","volume":"39","author":"Oner","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Wan, C.R., Muya, L., Kansara, V., and Ciulla, T.A. (2021). Suprachoroidal delivery of small molecules, nanoparticles, gene and cell therapies for ocular diseases. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020288"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Naftali Ben Haim, L., and Moisseiev, E. (2021). Drug delivery via the suprachoroidal space for the treatment of retinal diseases. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13070967"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1515\/med-2016-0048","article-title":"Platelet rich plasma: A short overview of certain bioactive components","volume":"11","author":"Pavlovic","year":"2016","journal-title":"Open Med."},{"key":"ref_80","first-page":"1120672120977824","article-title":"Umbilical cord-derived mesenchymal stem cell implantation in patients with optic atrophy","volume":"14","author":"Kahraman","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1158\/0008-5472.CAN-17-0994","article-title":"The biology of cancer exosomes: Insights and new perspectives","volume":"77","author":"Ruivo","year":"2017","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41467-020-15747-2","article-title":"A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells","volume":"11","author":"Sung","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: Key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/cas.13697","article-title":"Exosomes in cancer development and clinical applications","volume":"109","author":"Tai","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ymeth.2012.01.002","article-title":"Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes","volume":"56","author":"Tauro","year":"2012","journal-title":"Methods"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbrc.2013.12.070","article-title":"In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome","volume":"445","author":"Sinha","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Doyle, L., and Wang, M.Z. (2019). Overview of Extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells, 8.","DOI":"10.3390\/cells8070727"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.addr.2012.07.001","article-title":"Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery","volume":"65","author":"Yeo","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"8883616","DOI":"10.1155\/2020\/8883616","article-title":"Effect of mesenchymal stem cell-derived exosomes on retinal injury: A review of current findings","volume":"2020","author":"Nuzzi","year":"2020","journal-title":"Stem Cells Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.3390\/ijms15034142","article-title":"Exosomes derived from mesenchymal stem cells","volume":"15","author":"Yu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchemneu.2019.01.006","article-title":"UMSC-derived exosomes promote retinal ganglion cells survival in a rat model of optic nerve crush","volume":"96","author":"Pan","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1167\/iovs.18-25310","article-title":"Mesenchymal stem cell-derived small extracellular vesicles promote neuroprotection in a genetic DBA\/2J mouse model of glaucoma","volume":"59","author":"Mead","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13287-020-01702-x","article-title":"Extracellular vesicles derived from human ES-MSCs protect retinal ganglion cells and preserve retinal function in a rodent model of optic nerve injury","volume":"11","author":"Seyedrazizadeh","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41418-020-00636-4","article-title":"Photoreceptor protection by mesenchymal stem cell transplantation identifies exosomal MiR-21 as a therapeutic for retinal degeneration","volume":"28","author":"Deng","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/biof.1374","article-title":"Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential","volume":"43","author":"Volarevic","year":"2017","journal-title":"Biofactors"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4252\/wjsc.v11.i11.957","article-title":"Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells\u2014A clue to stem cell-based therapy","volume":"11","author":"Holan","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"34562","DOI":"10.1038\/srep34562","article-title":"Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.61.2.6","article-title":"TNF\u03b1-Mediated priming of mesenchymal stem cells enhances their neuroprotective effect on retinal ganglion cells","volume":"61","author":"Mead","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1002\/jcb.26726","article-title":"The extracellular vesicles-derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicine","volume":"119","author":"Nooshabadi","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M.M., Araujo, A.M., Araiz, M., and Fernandez-Mercado, M. (2016). New concepts in cancer biomarkers: Circulating miRNAs in liquid biopsies. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050627"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2011.11.026","article-title":"Blood serum miRNA: Non-invasive biomarkers for Alzheimer\u2019s disease","volume":"235","author":"Geekiyanage","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnmol.2013.00039","article-title":"MicroRNAs as biomarkers for CNS disease","volume":"6","author":"Rao","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jhg.2016.91","article-title":"MicroRNAs in glaucoma and neurodegenerative diseases","volume":"62","author":"Molasy","year":"2017","journal-title":"J. Hum. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/hmg\/ddy040","article-title":"Differentially expressed microRNAs in the aqueous humor of patients with exfoliation glaucoma or primary open-angle glaucoma","volume":"27","author":"Drewry","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1167\/iovs.18-24878","article-title":"Identification of candidate miRNA biomarkers for glaucoma","volume":"60","author":"Hindle","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.exer.2012.10.016","article-title":"MicroRNA in aqueous humor from patients with cataract","volume":"108","author":"Dunmire","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1038\/srep05089","article-title":"Profiles of extracellular miRNAs in the aqueous humor of glaucoma patients assessed with a microarray system","volume":"4","author":"Tanaka","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_111","first-page":"241","article-title":"Non-housekeeping genes expressed in human trabecular meshwork cell cultures","volume":"18","author":"Paylakhi","year":"2012","journal-title":"Mol. Vis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000450957","article-title":"Relationship between the pathogenesis of glaucoma and miRNA","volume":"57","author":"Guo","year":"2017","journal-title":"Ophthalmic Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/jcp.22476","article-title":"MicroRNA-24 regulates the processing of latent TGF\u03b21 during cyclic mechanical stress in human trabecular meshwork cells through direct targeting of FURIN","volume":"226","author":"Luna","year":"2011","journal-title":"J. Cell Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1167\/iovs.10-6448","article-title":"Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells","volume":"52","author":"Luna","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1167\/iovs.15-18036","article-title":"MicroRNA-483-3p inhibits extracellular matrix production by targeting Smad4 in human trabecular meshwork cells","volume":"56","author":"Shen","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Luna, C., Li, G., Huang, J., Qiu, J., Wu, J., Yuan, F., Epstein, D.L., and Gonzalez, P. (2012). Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051688"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1074\/jbc.M109.037127","article-title":"Targeting of integrin \u03b21 and kinesin 2\u03b1 by microRNA 183","volume":"285","author":"Li","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1167\/iovs.10-6708","article-title":"Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells","volume":"52","author":"Li","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1167\/iovs.15-18088","article-title":"MicroRNA expression in the glaucomatous retina","volume":"56","author":"Jayaram","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_120","first-page":"3694","article-title":"MicroRNA-96 regulates RGC-5 cell growth through caspase-dependent apoptosis","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Kong, N., Lu, X., and Li, B. (2014). Downregulation of microRNA-100 protects apoptosis and promotes neuronal growth in retinal ganglion cells. BMC Mol. Biol., 15.","DOI":"10.1186\/s12867-014-0025-1"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jmcb\/mjx022","article-title":"microRNA-21a-5p\/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma","volume":"9","author":"Su","year":"2017","journal-title":"J. Mol. Cell Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/11077\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:14:39Z","timestamp":1760166879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/11077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":122,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms222011077"],"URL":"https:\/\/doi.org\/10.3390\/ijms222011077","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,14]]}}}